Fidia Pharma Middle East FZE

Wholly owned subsidiary in the Middle East region.

logo ME
Continuing its International growth, Fidia farmaceutici, a world leader in hyaluronic acid R&D and manufacturing, announces the opening of a wholly owned subsidiary in the United Arab Emirates. A hub for its operations in the Middle East and North Africa (MENA), Fidia’s 6th subsidiary will be based in Dubai.

The Dubai subsidiary will also provide field support to Fidia farmaceutici’s customers and distributors in the region more thoroughly and effectively, to ensure they receive the highest quality service.

Fidia Pharma Middle East was formally inaugurated on December 1st, 2015 and employs highly professional and dedicated people, with a diversified product portfolio focusing on hyaluronic acid, with specialization in intra-articular Joint Care, Wound Care and Aesthetic Medicine.

The completion of this project further demonstrates Fidia’s transition into a truly global business, and strategic investment into key emerging markets, such as the Middle East.
 

Fidia Pharma Middle East is headquartered in Dubai

Health
Products
Website

Find out more about Fidia’s product portfolio:

Go to the website

Key Business Areas

Fidia operates in numerous therapeutic areas, providing specific, innovative treatments for commonly occurring pathologies with major socio-economic impact, namely:

- joint healthcare
- wound care
- dermatology
- neurology
- dermo-aesthetics
- ophthalmology